Finance

Lists
4896:TYO
K Pharma Inc
Â¥762.00
+1.60%
(+12.00) 1D
Oct 5, 9:37:42 AM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4896...
Open
Â¥765
High
Â¥765
Low
Â¥758
Mkt. cap
8.86B
Avg. vol.
17.80K
Volume
6.50K
52-wk high
Â¥949
52-wk low
Â¥604
EPS
-Â¥90
No. of employees
20
Open
Â¥765
High
Â¥765
Low
Â¥758
Mkt. cap
8.86B
Avg. vol.
17.80K
Volume
6.50K
52-wk high
Â¥949
52-wk low
Â¥604
EPS
-Â¥90
No. of employees
20
News stories
From web sources and news partners
About K Pharma Inc
CEO-
Employees20
FoundedNov 1, 2016
Headquarters-
SectorPharmaceutical industry
Websitekpharma.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
414.00M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
231.00M
-186.00M
237.00M
234.00M
Operating expense
231.00M
248.00M
237.00M
234.00M
Total operating expenses
231.00M
248.00M
237.00M
234.00M
Operating income
-231.00M
-248.00M
-237.00M
-234.00M
Other non operating income
-
-1.00M
-1.00M
1.00M
EBT including unusual items
-236.00M
-312.00M
-250.00M
-241.00M
EBT excluding unusual items
-229.00M
-256.00M
-243.00M
-241.00M
Income tax expense
1.00M
-
-
1.00M
Effective tax rate
-0.42%
-
-
-0.41%
Other operating expenses
-
20.00M
-
-
Net income
-237.00M
-312.00M
-250.00M
-242.00M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.00M
-
2.00M
-
Interest expense
-
-7.00M
-7.00M
-8.00M
Net interest expenses
2.00M
-7.00M
-5.00M
-8.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps